A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
Running, not enrolling · Phase 3
Conditions studied: Non-Small Cell Lung Cancer
In brief
This study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with eligible biomarker status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) NSCLC staging system.
Key facts
- Study ID
- NCT05170204
- Run by
- Hoffmann-La Roche
- People needed
- 68
- Starts
- 2022-11-01
- Expected to finish
- 2030-06-16
- Last updated by the study team
- 2026-08-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Northwest Cancer Specialists, P.C. — Tigard, Oregon, United States
- Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia
- One Clinical Research — Nedlands, Western Australia, Australia
- UZ Gent — Ghent, Belgium
- Hospital de Cancer de Barretos — Barretos, São Paulo, Brazil
- Instituto do Cancer do Estado de Sao Paulo - ICESP — São Paulo, São Paulo, Brazil
- RedSalud Vitacura — Santiago, Chile
- Hunan Cancer Hospital — Changsha, China
- Xinqiao Hospital of Third Military Medical University — Chongqing, China
- Shandong Cancer Hospital — Jinan, China
- Shanghai Pulmonary Hospital — Shanghai, China
- Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo — Bogota, D.C., Colombia
- Hospital Universitario San Ignacio — Bogotá, Colombia
- Centre Francois Baclesse — Caen, France
- Centre Leon Berard — Lyon, France
- Hopital Nord — Marseille, France
- Helios Klinikum Emil von Behring GmbH — Berlin, Germany
- IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola — Meldola, Emilia-Romagna, Italy
- Asst Grande Ospedale Metropolitano Niguarda — Milan, Lombardy, Italy
- NHO Kyushu Cancer Center — Fukuoka, Japan
- Kurume University Hospital — Fukuoka, Japan
- Kobe City Medical Center General Hospital — Hyōgo, Japan
- Kagoshima University Hospital — Kagoshima, Japan
- Kumamoto University Hospital — Kumamoto, Japan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.